Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Allon Therapeutics Inc NPCUF

Allon Therapeutics, Inc. is a Canada-based Company, which develops treatments for neurodegenerative diseases. The Company is engaged in pre-clinical and clinical development of proprietary neuroprotective compounds which may be applied for the potential treatment of Alzheimer's Disease, Parkinson's Disease, senile dementia, glaucoma, traumatic head injury, neuronal damage due to stroke and... see more

GREY:NPCUF - Post Discussion

Allon Therapeutics Inc > Analyst Recommendation
View:
Post by retiredcf on Jul 16, 2017 12:32pm

Analyst Recommendation

First stock in the clip. GLTA

https://www.bnn.ca/video/bob-mcwhirter-discusses-grande-west-transportation~1167807

2017-07-14 PAST TOP PICK Michael Smedley
 
(A Top Pick June 9/16. Up 6.9%.) He is very pleased with this because it has been underwater for a time. It has reconstituted itself with a management change at the top. It’s into infrastructure and electrical systems. Feels it is on the way to becoming something quite important, especially in the Northeast US where they bought a subsidiary a couple of years ago.
 
Login to show your approval   Login to show your disapproval / Be the first to comment
Price:
$1.240
Subject:
CANADIAN
Bias:
UNKNOWN
Owned:
Yes
Comment by biggerbucks on Jul 17, 2017 1:15am
I think this may be the little stock that could  all goes well neww ceo gets creative we may be 4  -  6$ a share I know thats a stretch but I have seen this before a great sound little company gets new upper management with some great new ambition and we are on the move and its in the wright buisiness as I see it Good luck guys
Comment by flogshot on Jul 18, 2017 9:55pm
Desjardins is talking about a perspective of 1.90 $ https://www.disnat.com/centre-apprentissage/articles-experts/titres-a-privilegier/2017-07?oft_id=6874972&oft_k=2pqSQz0g&oft_lk=zlYaTF&oft_d=636360116994800000#article1
Comment by retiredcf on Jul 23, 2017 11:11am
I just noticed that I posted the wrong clip. Try the first stock in this one. As always, Michael Smedley is a bit of an acquired taste but he has found some good stocks over the years. GLTA https://www.bnn.ca/market-call-tonight/michael-smedley-s-past-picks~1168014
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities